Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Not Confirmed
Not Confirmed
03-05 September, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Industry Trade Show
Not Confirmed
03-05 September, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
23 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-announces-2025-interim-financial-results-highlighting-encouraging-data-from-midlate-stage-clinical-programs-and-its-innovative-tce-technology-platform-302536610.html
19 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengenes-atg-022-cldn18-2-adc-granted-breakthrough-therapy-designation-for-the-treatment-of-gastricgastroesophageal-junction-adenocarcinoma-302533326.html
23 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-to-present-latest-clinical-results-from-two-studies-in-cpi-resistant-solid-tumors-at-asco-2025-302463999.html
21 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-enters-into-a-global-clinical-collaboration-with-msd-to-evaluate-atg-022-cldn18-2-adc-in-combination-with-keytruda-pembrolizumab-302460200.html
25 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-presents-four-posters-at-aacr-2025-highlighting-focuses-on-antengagertm-tces-and-synthetic-lethality-302438082.html
23 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-to-present-latest-results-from-two-clinical-studies-at-asco-2025-302436703.html
ABOUT THIS PAGE